Media ReleaseFrom: New Zealand Medical Association (NZMA)
- About 700 cancer patients around New Zealand have completed the questionnaire.
- Cancer patients reported strong enthusiasm in clinical trials participation and this was seen across different age, gender, tumour types and location.
- Many patients felt that trial participation could help themselves as well as others.
- Some reported fear of randomization as a main disincentive in enrolling clinical trials. This could be improved by education on clinical equipoise.
- We need to assess barriers at the level of clinicians and institution, as there is strong interest in clinical trials from New Zealand cancer patients.
Clinical trials often provide access to unfunded or investigational treatments and trial participation has improved cancer outcome around the world. To better understand why New Zealand has low clinical trials participation rates, we conducted a qualitative survey of cancer patients around New Zealand to determine what barriers are present at patient level.
Our patients reported strong enthusiasm in clinical trials across age, tumour group, demographics and location. Majority wanted to participate in clinical trials/ research to help others but few patients felt that fear of randomization held them back from participating in clinical trials.